ER+/HER2+ Metastatic Breast Cancer
2 Görünümler
• 07/03/23
0
0
gömmek
administrator
Aboneler
Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar